Cite
MLA Citation
L. Yang et al.. “2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis.” European journal of cancer, vol. 51, n.d., pp. S524–. http://access.bl.uk/ark:/81055/vdc_100030628262.0x000041